Evidence map›Paper›PMID 20801768›Full record

ArticleRNA (New York, N.Y.)2010

RPL30 regulation of splicing reveals distinct roles for Cbp80 in U1 and U2 snRNP cotranscriptional recruitment.

Mireia Bragulat, Markus Meyer, Sara Macías, Maria Camats, Mireia Labrador, Josep Vilardell

Open access · hybridAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mireia BragulatCentre de Regulació Genòmica, Barcelona, Spain.
Markus Meyer
Sara Macías
Maria Camats
Mireia Labrador
Josep Vilardell
Centre for Genomic Regulation · ESInstitució Catalana de Recerca i Estudis Avançats · ESInstitut de Biologia Molecular de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-mRNA splicing is catalyzed by the spliceosome, and its control is essential for correct gene expression. While splicing repressors typically interfere with transcript recognition by spliceosomal components, the yeast protein L30 blocks spliceosomal rearrangements required for the engagement of U2 snRNP (small ribonucleoprotein particle) to its own transcript RPL30. Using a mutation in the RPL30 binding site that disrupts this repression, we have taken a genetic approach to reveal that regulation of splicing is restored in this mutant by deletion of the cap-binding complex (CBC) component Cbp80. Indeed, our data indicate that Cbp80 plays distinct roles in the recognition of the intron by U1 and U2 snRNP. It promotes the initial 5' splice site recognition by U1 and, independently, facilitates U2 recruitment, depending on sequences located in the vicinity of the 5' splice site. These results reveal a novel function for CBC in splicing and imply that these molecular events can be the target of a splicing regulator.

Indexed as

RNA SplicingAmino Acid SequenceBase SequenceDNA PrimersExonsGene DeletionGenes, FungalModels, BiologicalMolecular Sequence DataMutationNuclear ProteinsNucleic Acid ConformationRibonucleoprotein, U1 Small NuclearRibonucleoprotein, U2 Small NuclearRibosomal ProteinsRNA Cap-Binding ProteinsDNA PrimersNuclear ProteinsRibonucleoprotein, U1 Small NuclearRibonucleoprotein, U2 Small Nuclearribosomal protein L30Ribosomal ProteinsRNA Cap-Binding ProteinsRNA, FungalRNA PrecursorsRNA Splice SitesSaccharomyces cerevisiae ProteinsSTO1 protein, S cerevisiae

Identifiers

PMID20801768
PMCPMC2941111
OpenAlexW2100176229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.